| Literature DB >> 11195405 |
R R Bahnson1, G E Hanks, R P Huben, P Kantoff, J M Kozlowski, M Kuettel, P H Lange, C Logothetis, J M Pow-Sang, M Roach, H Sandler, P T Scardino, R J Taylor, D A Urban, P C Walsh, T G Wilson.
Abstract
Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.Entities:
Mesh：
Year: 2000 PMID： 11195405
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990